Advertisement

TNF/TNF Receptors

  • Jörn M. Schattenberg
  • Mark J. CzajaEmail author
Chapter

Abstract

Tumor necrosis factor-α (TNF) is a pleiotropic cyto­kine whose biological functions regulate the cellular responses of injury and repair, inflammation and immunity, and proliferation. In the liver, TNF exerts autocrine and paracrine effects that mediate a variety of pathophysiological states that involve liver injury and cell death and/or hepatocellular proliferation. Thus, TNF is a central regulator of hepatic physiology and delineation of the complex signaling pathways that mediate the disparate effects of this cytokine has contributed to our understanding of its function. In particular, investigations have attempted to determine how this factor could promote either cell proliferation or death in hepatocytes under different physiologic circumstances. With these studies has come an increased understanding of the complex events that determine whether a hepatocyte undergoes apoptosis or proliferation following TNF stimulation. This chapter will focus initially on signaling events that follow TNF ligand–receptor interaction, and subsequently on the precise functions of TNF signaling in specific pathophysiologic states. Although considerable progress has been made in defining TNF signaling pathways in hepatocytes, the challenge remains to determine how these signal cascades regulate disease states in order to mani­pulate these pathways for the treatment of human liver diseases.

Keywords

Liver Regeneration Partial Hepatectomy Human Liver Disease Mitochondrial Death Pathway Hepatocyte Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Supported in part by National Institutes of Health grants DK044234 and DK061498 to MJC and a Deutsche Forschungsgemeinschaft (DFG) grant to JMS.

References

  1. 1.
    Kern PA, Ranganathan S, Li C et al (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745–E751Google Scholar
  2. 2.
    Loffreda S, Rai R, Yang SQ et al (1997) Bile ducts and portal and central veins are major producers of tumor necrosis factor α in regenerating rat liver. Gastroenterology 112:2089–2098PubMedGoogle Scholar
  3. 3.
    Vandenabeele P, Declercq R, Beyaert W, Fiers W (1988) Two tumor necrosis factor receptors: structure and function. Trends Cell Biol 5:392–399Google Scholar
  4. 4.
    Banner DW, D’Arcy A, Janes W et al (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF β complex: implications for TNF receptor activation. Cell 73: 431–445PubMedGoogle Scholar
  5. 5.
    Black RA, Rauch CT, Kozlosky CJ et al (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729–733PubMedGoogle Scholar
  6. 6.
    Moss ML, Lambert MH (2002) Shedding of membrane proteins by ADAM family proteases. Essays Biochem 38: 141–153PubMedGoogle Scholar
  7. 7.
    Amour A, Slocombe PM, Webster A et al (1998) TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435:39–44PubMedGoogle Scholar
  8. 8.
    Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10:45–65PubMedGoogle Scholar
  9. 9.
    Chan FK, Chun HJ, Zheng L et al (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288:2351–2354PubMedGoogle Scholar
  10. 10.
    Wang H, Czura CJ, Tracey KJ (2003) Tumor necrosis factor. In: Thomson AW, Lotze MT (eds) The Cytokine Handbook, 4th edn. Academic, Amsterdam, pp 837–860Google Scholar
  11. 11.
    Grell M, Douni E, Wajant H et al (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793–802PubMedGoogle Scholar
  12. 12.
    Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745–756PubMedGoogle Scholar
  13. 13.
    Kresse M, Latta M, Kunstle G et al (2005) Kupffer cell-expressed membrane-bound TNF mediates melphalan hepatotoxicity via activation of both TNF receptors. J Immunol 175:4076–4083PubMedGoogle Scholar
  14. 14.
    Hehlgans T, Seitz C, Lewis C, Mannel DN (2001) Hypoxic upregulation of TNF receptor type 2 expression involves NF-IL-6 and is independent of HIF-1 or HIF-2. J Interferon Cytokine Res 21:757–762PubMedGoogle Scholar
  15. 15.
    Grell M, Wajant H, Zimmermann G, Scheurich P (1998) The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. PNAS 95:570–575PubMedGoogle Scholar
  16. 16.
    Barbara JA, Smith WB, Gamble JR et al (1994) Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor and p75 receptor-selective TNF-α mutants. EMBO J 13:843–850PubMedGoogle Scholar
  17. 17.
    Tartaglia LA, Pennica D, Goeddel DV (1993) Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18542–18548PubMedGoogle Scholar
  18. 18.
    Fotin-Mleczek M, Henkler F, Samel D et al (2002) Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 115:2757–2770PubMedGoogle Scholar
  19. 19.
    Depuydt B, van Loo G, Vandenabeele P, Declercq W (2005) Induction of apoptosis by TNF receptor 2 in a T-cell hybridoma is FADD dependent and blocked by caspase-8 inhibitors. J Cell Sci 118:497–504PubMedGoogle Scholar
  20. 20.
    Masli S, Turpie B (2008) Anti-inflammatory effects of tumour necrosis factor (TNF)-α are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-β-treated antigen-­presenting cells. Immunology 127:62–72Google Scholar
  21. 21.
    Baumel M, Lechner A, Hehlgans T, Mannel DN (2008) Enhanced susceptibility to Con A-induced liver injury in mice transgenic for the intracellular isoform of human TNF receptor type 2. J Leukoc Biol 84:162–169PubMedGoogle Scholar
  22. 22.
    Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149–160PubMedGoogle Scholar
  23. 23.
    Peschon JJ, Slack JL, Reddy P et al (1998) An essential role for ectodomain shedding in mammalian development. Science 282:1281–1284PubMedGoogle Scholar
  24. 24.
    Streetz K, Leifeld L, Grundmann D et al (2000) Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119:446–460PubMedGoogle Scholar
  25. 25.
    Volpes R, van den Oord JJ, De Vos R, Desmet VJ (1992) Hepatic expression of type A and type B receptors for tumor necrosis factor. J Hepatol 14:361–369PubMedGoogle Scholar
  26. 26.
    Czaja MJ, Xu J, Alt E (1995) Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 108:1849–1854PubMedGoogle Scholar
  27. 27.
    Legler DF, Micheau O, Doucey MA et al (2003) Recruitment of TNF receptor 1 to lipid rafts is essential for TNFα-mediated NF-κB activation. Immunity 18:655–664PubMedGoogle Scholar
  28. 28.
    Ashkenazi A, Dixit VM (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11:255–260PubMedGoogle Scholar
  29. 29.
    Hsu H, Shu HB, Pan MG, Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299–308PubMedGoogle Scholar
  30. 30.
    Peter ME, Krammer PH (2003) The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10:26–35PubMedGoogle Scholar
  31. 31.
    Bhardwaj A, Aggarwal BB (2003) Receptor-mediated choreography of life and death. J Clin Immunol 23:317–332PubMedGoogle Scholar
  32. 32.
    Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495–504PubMedGoogle Scholar
  33. 33.
    Jiang Y, Woronicz JD, Liu W, Goeddel DV (1999) Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283:543–546PubMedGoogle Scholar
  34. 34.
    Chinnaiyan AM, Tepper CG, Seldin MF et al (1996) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271:4961–4965PubMedGoogle Scholar
  35. 35.
    Chinnaiyan AM, O’Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505–512PubMedGoogle Scholar
  36. 36.
    Ermolaeva MA, Michallet MC, Papadopoulou N et al (2008) Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 9:1037–1046PubMedGoogle Scholar
  37. 37.
    Tibbetts MD, Zheng L, Lenardo MJ (2003) The death effector domain protein family: regulators of cellular homeostasis. Nat Immunol 4:404–409PubMedGoogle Scholar
  38. 38.
    Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312–1316PubMedGoogle Scholar
  39. 39.
    Earnshaw WC, Martins LM, Kaufmann SH (1999) Mam­malian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383–424PubMedGoogle Scholar
  40. 40.
    Kischkel FC, Hellbardt S, Behrmann I et al (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579–5588PubMedGoogle Scholar
  41. 41.
    Muzio M, Stockwell BR, Stennicke HR et al (1998) An induced proximity model for caspase-8 activation. J Biol Chem 273:2926–2930PubMedGoogle Scholar
  42. 42.
    Juo P, Kuo CJ, Yuan J, Blenis J (1998) Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 8:1001–1008PubMedGoogle Scholar
  43. 43.
    Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181–190PubMedGoogle Scholar
  44. 44.
    Yeh WC, Itie A, Elia AJ et al (2000) Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12:633–642PubMedGoogle Scholar
  45. 45.
    Harper N, Hughes M, MacFarlane M, Cohen GM (2003) Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J Biol Chem 278:25534–25541PubMedGoogle Scholar
  46. 46.
    Bradham CA, Qian T, Streetz K et al (1998) The mitochondrial permeability transition is required for tumor necrosis factor α-mediated apoptosis and cytochrome c release. Mol Cell Biol 18:6353–6364PubMedGoogle Scholar
  47. 47.
    Barnhart BC, Alappat EC, Peter ME (2003) The CD95 type I/ type II model. Semin Immunol 15:185–193PubMedGoogle Scholar
  48. 48.
    Wei MC, Zong WX, Cheng EH et al (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727–730PubMedGoogle Scholar
  49. 49.
    Zhao Y, Ding WX, Qian T et al (2003) Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. Gastroenterology 125: 854–867PubMedGoogle Scholar
  50. 50.
    Zhao Y, Li S, Childs EE et al (2001) Activation of pro-death Bcl-2 family proteins and mitochondria apoptosis pathway in tumor necrosis factor-α-induced liver injury. J Biol Chem 276:27432–27440PubMedGoogle Scholar
  51. 51.
    Chen X, Ding WX, Ni HM et al (2007) Bid-independent mitochondrial activation in tumor necrosis factor α-induced apoptosis and liver injury. Mol Cell Biol 27:541–553PubMedGoogle Scholar
  52. 52.
    Zou H, Li Y, Liu X, Wang X (1999) An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274:11549–11556PubMedGoogle Scholar
  53. 53.
    Scaffidi C, Fulda S, Srinivasan A et al (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675–1687PubMedGoogle Scholar
  54. 54.
    de la Coste A, Fabre M, McDonell N et al (1999) Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am J Physiol 277:G702–G708Google Scholar
  55. 55.
    Van Molle W, Denecker G, Rodriguez I et al (1999) Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J Immunol 163:5235–5241PubMedGoogle Scholar
  56. 56.
    Deng Y, Ren X, Yang L et al (2003) A JNK-dependent pathway is required for TNFα-induced apoptosis. Cell 115:61–70PubMedGoogle Scholar
  57. 57.
    Guicciardi ME, Deussing J, Miyoshi H et al (2000) Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106:1127–1137PubMedGoogle Scholar
  58. 58.
    Werneburg N, Guicciardi ME, Yin XM, Gores GJ (2004) TNF-α-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent. Am J Physiol Gastrointest Liver Physiol 287:G436–G443Google Scholar
  59. 59.
    Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ (2002) Tumor necrosis factor-α-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol 283:G947–G956Google Scholar
  60. 60.
    Li S, Zhao Y, He X et al (2002) Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J Biol Chem 277:26912–26920PubMedGoogle Scholar
  61. 61.
    Jones BE, Lo CR, Liu H et al (2000) Hepatocytes sensitized to tumor necrosis factor-α cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J Biol Chem 275:705–712PubMedGoogle Scholar
  62. 62.
    Kunstle G, Hentze H, Germann PG et al (1999) Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation. Hepatology 30:1241–1251PubMedGoogle Scholar
  63. 63.
    Liu H, Jones BE, Bradham C, Czaja MJ (2002) Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-α. Am J Physiol Gastrointest Liver Physiol 282:G257–G266Google Scholar
  64. 64.
    Moorthy AK, Ghosh G (2003) p105-IκBγ and prototypical IκBs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-κB. J Biol Chem 278:556–566PubMedGoogle Scholar
  65. 65.
    Solan NJ, Miyoshi H, Carmona EM et al (2002) RelB cellular regulation and transcriptional activity are regulated by p100. J Biol Chem 277:1405–1418PubMedGoogle Scholar
  66. 66.
    Ghosh S, Karin M (2002) Missing pieces in the NF-κB puzzle. Cell 109:S81–S96Google Scholar
  67. 67.
    Park YC, Ye H, Hsia C et al (2000) A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 101:777–787PubMedGoogle Scholar
  68. 68.
    Park YC, Burkitt V, Villa AR et al (1999) Structural basis for self-association and receptor recognition of human TRAF2. Nature 398:533–538PubMedGoogle Scholar
  69. 69.
    Tada K, Okazaki T, Sakon S et al (2001) Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J Biol Chem 276: 36530–36534PubMedGoogle Scholar
  70. 70.
    Perkins ND (2000) The Rel/NF-κB family: friend and foe. Trends Biochem Sci 25:434–440PubMedGoogle Scholar
  71. 71.
    Devin A, Cook A, Lin Y et al (2000) The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12:419–429PubMedGoogle Scholar
  72. 72.
    Devin A, Lin Y, Yamaoka S et al (2001) The α and β subunits of IκB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol Cell Biol 21:3986–3994PubMedGoogle Scholar
  73. 73.
    Neumann M, Grieshammer T, Chuvpilo S et al (1995) RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J 14:1991–2004PubMedGoogle Scholar
  74. 74.
    Leitges M, Sanz L, Martin P et al (2001) Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol Cell 8:771–780PubMedGoogle Scholar
  75. 75.
    Oliver FJ, Menissier-de Murcia J, Nacci C et al (1999) Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18:4446–4454PubMedGoogle Scholar
  76. 76.
    Wang D, Westerheide SD, Hanson JL, Baldwin AS Jr (2000) Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 275:32592–32597PubMedGoogle Scholar
  77. 77.
    Beg AA, Sha WC, Bronson RT et al (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167–170PubMedGoogle Scholar
  78. 78.
    Alcamo E, Mizgerd JP, Horwitz BH et al (2001) Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J Immunol 167:1592–1600PubMedGoogle Scholar
  79. 79.
    Xu Y, Bialik S, Jones BE et al (1998) NF-κB inactivation converts a hepatocyte cell line TNF-α response from proliferation to apoptosis. Am J Physiol 275:C1058–C1066Google Scholar
  80. 80.
    Osawa Y, Banno Y, Nagaki M et al (2001) TNF-α-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J Immunol 167:173–180PubMedGoogle Scholar
  81. 81.
    Hatano E, Brenner DA (2001) Akt protects mouse hepatocytes from TNF-α- and Fas-mediated apoptosis through NK-κB activation. Am J Physiol Gastrointest Liver Physiol 281: G1357–G1368Google Scholar
  82. 82.
    Li Q, Van Antwerp D, Mercurio F et al (1999) Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284:321–325PubMedGoogle Scholar
  83. 83.
    Rudolph D, Yeh WC, Wakeham A et al (2000) Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice. Genes Dev 14:854–862PubMedGoogle Scholar
  84. 84.
    Luedde T, Assmus U, Wustefeld T et al (2005) Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 115:849–859PubMedGoogle Scholar
  85. 85.
    Beraza N, Ludde T, Assmus U et al (2007) Hepatocyte-specific IKK γ/NEMO expression determines the degree of liver injury. Gastroenterology 132:2504–2517PubMedGoogle Scholar
  86. 86.
    Leist M, Gantner F, Bohlinger I et al (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 153:1778–1788PubMedGoogle Scholar
  87. 87.
    Hatano E, Bennett BL, Manning AM et al (2001) NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α- and Fas-mediated apoptosis. Gastroenterology 120:1251–1262PubMedGoogle Scholar
  88. 88.
    Liu H, Lo CR, Czaja MJ (2002) NF-κB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 35:772–778PubMedGoogle Scholar
  89. 89.
    Czaja MJ (2003) The future of GI and liver research: editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death. Am J Physiol Gastrointest Liver Physiol 284:G875–G879Google Scholar
  90. 90.
    Chang L, Kamata H, Solinas G et al (2006) The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIP(L) turnover. Cell 124:601–613PubMedGoogle Scholar
  91. 91.
    De Smaele E, Zazzeroni F, Papa S et al (2001) Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling. Nature 414:308–313PubMedGoogle Scholar
  92. 92.
    Schwabe RF, Uchinami H, Qian T et al (2004) Differential requirement for c-Jun NH2-terminal kinase in TNFα- and Fas-mediated apoptosis in hepatocytes. FASEB J 18:720–722PubMedGoogle Scholar
  93. 93.
    Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239–252PubMedGoogle Scholar
  94. 94.
    Tuncman G, Hirosumi J, Solinas G et al (2006) Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci U S A 103:10741–10746PubMedGoogle Scholar
  95. 95.
    Wang Y, Singh R, Lefkowitch JH et al (2006) Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J Biol Chem 281:15258–15267PubMedGoogle Scholar
  96. 96.
    Ni HM, Chen X, Ding WX et al (2008) Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. Am J Pathol 173:962–972Google Scholar
  97. 97.
    Lee TH, Huang Q, Oikemus S et al (2003) The death domain kinase RIP1 is essential for tumor necrosis factor α signaling to p38 mitogen-activated protein kinase. Mol Cell Biol 23:8377–8385PubMedGoogle Scholar
  98. 98.
    Akerman P, Cote P, Yang SQ et al (1992) Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol 263:G579–G585Google Scholar
  99. 99.
    Yamada Y, Kirillova I, Peschon JJ, Fausto N (1997) Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 94:1441–1446PubMedGoogle Scholar
  100. 100.
    Yamada Y, Webber EM, Kirillova I et al (1998) Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 28:959–970PubMedGoogle Scholar
  101. 101.
    Yamada Y, Fausto N (1998) Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 152: 1577–1589PubMedGoogle Scholar
  102. 102.
    Cressman DE, Greenbaum LE, DeAngelis RA et al (1996) Liver failure and defective hepatocyte regeneration in interleukin- 6-deficient mice. Science 274:1379–1383PubMedGoogle Scholar
  103. 103.
    Li W, Liang X, Kellendonk C et al (2002) STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277:28411–28417PubMedGoogle Scholar
  104. 104.
    Blindenbacher A, Wang X, Langer I et al (2003) Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 38:674–682PubMedGoogle Scholar
  105. 105.
    Sakamoto T, Liu Z, Murase N et al (1999) Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 29:403–411PubMedGoogle Scholar
  106. 106.
    Wuestefeld T, Klein C, Streetz KL et al (2003) Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 278:11281–11288PubMedGoogle Scholar
  107. 107.
    Dierssen U, Beraza N, Lutz HH et al (2008) Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration. J Biol Chem 283:9886–9895PubMedGoogle Scholar
  108. 108.
    Iimuro Y, Nishiura T, Hellerbrand C et al (1998) NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 101:802–811PubMedGoogle Scholar
  109. 109.
    DeAngelis RA, Kovalovich K, Cressman DE, Taub R (2001) Normal liver regeneration in p50/nuclear factor κB1 knockout mice. Hepatology 33:915–924PubMedGoogle Scholar
  110. 110.
    Rai RM, Lee FY, Rosen A et al (1998) Impaired liver regeneration in inducible nitric oxide synthase deficient mice. Proc Natl Acad Sci U S A 95:13829–13834PubMedGoogle Scholar
  111. 111.
    Chaisson ML, Brooling JT, Ladiges W et al (2002) Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 110:193–202PubMedGoogle Scholar
  112. 112.
    Maeda S, Chang L, Li ZW et al (2003) IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19:725–737PubMedGoogle Scholar
  113. 113.
    Malato Y, Sander LE, Liedtke C et al (2008) Hepatocyte-specific inhibitor-of-κB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration. Hepatology 47:2036–2050PubMedGoogle Scholar
  114. 114.
    Akerman PA, Cote PM, Yang SQ et al (1993) Long-term ethanol consumption alters the hepatic response to the regenerative effects of tumor necrosis factor-α. Hepatology 17:1066–1073PubMedGoogle Scholar
  115. 115.
    Yang SQ, Lin HZ, Yin M et al (1998) Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am J Physiol 275:G696–G704Google Scholar
  116. 116.
    Czaja MJ, Flanders KC, Biempica L et al (1989) Expression of tumor necrosis factor-α and transforming growth factor-β 1 in acute liver injury. Growth Factors 1:219–226PubMedGoogle Scholar
  117. 117.
    McClain CJ, Hill DB, Song Z et al (2002) Monocyte activation in alcoholic liver disease. Alcohol 27:53–61PubMedGoogle Scholar
  118. 118.
    Morio LA, Chiu H, Sprowles KA et al (2001) Distinct roles of tumor necrosis factor-α and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol 172:44–51PubMedGoogle Scholar
  119. 119.
    Yin M, Wheeler MD, Kono H et al (1999) Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice. Gastroenterology 117:942–952PubMedGoogle Scholar
  120. 120.
    Honchel R, Marsano L, Cohen D et al (1991) Lead enhances lipopolysaccharide and tumor necrosis factor liver injury. J Lab Clin Med 117:202–208PubMedGoogle Scholar
  121. 121.
    Czaja MJ, Schilsky ML, Xu Y et al (1994) Induction of MnSOD gene expression in a hepatic model of TNF-α toxicity does not result in increased protein. Am J Physiol 266:G737–G744Google Scholar
  122. 122.
    Xu Y, Jones BE, Neufeld DS, Czaja MJ (1998) Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor toxicity. Gastroenterology 115:1229–1237PubMedGoogle Scholar
  123. 123.
    Lou H, Kaplowitz N (2007) Glutathione depletion down-regulates tumor necrosis factor α-induced NF-κB activity via IκB kinase-dependent and -independent mechanisms. J Biol Chem 282:29470–29481PubMedGoogle Scholar
  124. 124.
    Colell A, Garcia-Ruiz C, Miranda M et al (1998) Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 115:1541–1551PubMedGoogle Scholar
  125. 125.
    Mandrekar P, Catalano D, Jeliazkova V, Kodys K (2008) Alcohol exposure regulates heat shock transcription factor binding and heat shock proteins 70 and 90 in monocytes and macrophages: implication for TNF-α regulation. J Leukoc Biol 84:1335–1345Google Scholar
  126. 126.
    Haouzi D, Lekehal M, Tinel M et al (2001) Prolonged, but not acute, glutathione depletion promotes Fas-mediated mitochondrial permeability transition and apoptosis in mice. Hepatology 33:1181–1188PubMedGoogle Scholar
  127. 127.
    Koteish A, Yang S, Lin H et al (2002) Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J Biol Chem 277:13037–13044PubMedGoogle Scholar
  128. 128.
    Li J, Bombeck CA, Yang S et al (1999) Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem 274:17325–17333PubMedGoogle Scholar
  129. 129.
    Arvelo MB, Cooper JT, Longo C et al (2002) A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35:535–543PubMedGoogle Scholar
  130. 130.
    Sass G, Shembade ND, Haimerl F et al (2007) TNF pretreatment interferes with mitochondrial apoptosis in the mouse liver by A20-mediated down-regulation of Bax. J Immunol 179:7042–7049PubMedGoogle Scholar
  131. 131.
    Tracey D, Klareskog L, Sasso EH et al (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117:244–279PubMedGoogle Scholar
  132. 132.
    Naveau S, Chollet-Martin S, Dharancy S et al (2004) A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 39:1390–1397PubMedGoogle Scholar
  133. 133.
    Spahr L, Rubbia-Brandt L, Frossard JL et al (2002) Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol 37:448–455PubMedGoogle Scholar
  134. 134.
    Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231PubMedGoogle Scholar
  135. 135.
    Marchesini G, Bugianesi E, Forlani G et al (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–923PubMedGoogle Scholar
  136. 136.
    Diehl AM (2005) Lessons from animal models of NASH. Hepatol Res 33:138–144PubMedGoogle Scholar
  137. 137.
    De Taeye BM, Novitskaya T, McGuinness OP et al (2007) Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab 293:E713–E725Google Scholar
  138. 138.
    Dela PA, Leclercq I, Field J et al (2005) NF-κB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129: 1663–1674Google Scholar
  139. 139.
    Nguyen MT, Satoh H, Favelyukis S et al (2005) JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3–L1 adipocytes. J Biol Chem 280:35361–35371PubMedGoogle Scholar
  140. 140.
    Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610–614PubMedGoogle Scholar
  141. 141.
    Endo M, Masaki T, Seike M, Yoshimatsu H (2007) TNF-α induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med (Maywood) 232:614–621Google Scholar
  142. 142.
    Crespo J, Cayon A, Fernandez-Gil P et al (2001) Gene expres­sion of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34:1158–1163PubMedGoogle Scholar
  143. 143.
    Hui JM, Hodge A, Farrell GC et al (2004) Beyond insulin resistance in NASH: TNF-α or adiponectin? Hepatology 40:46–54PubMedGoogle Scholar
  144. 144.
    Ruiz AG, Casafont F, Crespo J et al (2007) Lipopoly­saccharide-binding protein plasma levels and liver TNF-α gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 17:1374–1380PubMedGoogle Scholar
  145. 145.
    Poniachik J, Csendes A, Diaz JC et al (2006) Increased production of IL-1α and TNF-α in lipopolysaccharide-­stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine 33:252–257PubMedGoogle Scholar
  146. 146.
    Tokushige K, Takakura M, Tsuchiya-Matsushita N et al (2007) Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol 46: 1104–1110PubMedGoogle Scholar
  147. 147.
    Valenti L, Fracanzani AL, Dongiovanni P et al (2002) Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastro­enterology 122:274–280PubMedGoogle Scholar
  148. 148.
    Tokushige K, Hashimoto E, Tsuchiya N et al (2005) Clinical significance of soluble TNF receptor in Japanese patients with non-alcoholic steatohepatitis. Alcohol Clin Exp Res 29:298S–303SPubMedGoogle Scholar
  149. 149.
    Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N (2007) Association of HLA-DRB1*13 and TNF-α gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 14:841–848PubMedGoogle Scholar
  150. 150.
    Suneetha PV, Sarin SK, Goyal A et al (2006) Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver disease. J Hepatol 44:856–863PubMedGoogle Scholar
  151. 151.
    Biermer M, Puro R, Schneider RJ (2003) Tumor necrosis factor α inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-κB. J Virol 77:4033–4042PubMedGoogle Scholar
  152. 152.
    Shi H, Guan SH (2008) Increased apoptosis in HepG2.2.15 cells with hepatitis B virus expression by synergistic induction of interferon-gamma and tumour necrosis factor-α. Liver Int 29:349–355PubMedGoogle Scholar
  153. 153.
    Yared G, Hussain KB, Nathani MG et al (1998) Cytokine-mediated apoptosis and inhibition of virus production and anchorage independent growth of viral transfected hepatoblastoma cells. Cytokine 10:586–595PubMedGoogle Scholar
  154. 154.
    Kim WH, Hong F, Jaruga B et al (2005) Hepatitis B virus X protein sensitizes primary mouse hepatocytes to ethanol- and TNF-α-induced apoptosis by a caspase-3-dependent mechanism. Cell Mol Immunol 2:40–48PubMedGoogle Scholar
  155. 155.
    Wang WH, Gregori G, Hullinger RL, Andrisani OM (2004) Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) ­receptor 1/TNF-α expression. Mol Cell Biol 24: 10352–10365PubMedGoogle Scholar
  156. 156.
    Kim KH, Seong BL (2003) Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J 22: 2104–2116PubMedGoogle Scholar
  157. 157.
    Su F, Theodosis CN, Schneider RJ (2001) Role of NF-κB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol 75:215–225PubMedGoogle Scholar
  158. 158.
    Hassan M, Ghozlan H, Abdel-Kader O (2005) Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology 333:324–336PubMedGoogle Scholar
  159. 159.
    Hassan M, Selimovic D, Ghozlan H, Abdel-Kader O (2007) Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) α by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-κB-dependent activation. Cell Signal 19:301–311PubMedGoogle Scholar
  160. 160.
    Marusawa H, Hijikata M, Chiba T, Shimotohno K (1999) Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor α-mediated apoptosis via NF-κB activation. J Virol 73:4713–4720PubMedGoogle Scholar
  161. 161.
    Zhu N, Khoshnan A, Schneider R et al (1998) Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72:3691–3697PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Marion Bessin Liver Research CenterAlbert Einstein College of MedicineBronxUSA

Personalised recommendations